Hypothesis was that hepatic insulin resistance (secondary to hepatic steatosis) via defective glucagon signaling/ glucagon resistance would lead to impaired ureagenesis and, hence, increased plasma concentrations of glucagonotropic amino acids and, subsequently, glucagon. The gene discussed is INS; the disease is fatty liver disease.